Low serum calcium: new, important indicator of COVID-19 patients from mild to severe

May 20, 2021

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally.1 Confirmed cases and deaths have been reported in more than 200 countries worldwide.2  While 80% of COVID-19 infections have less severe clinical symptoms (low-grade fever, cough, fatigue) with no evidence of pneumonia or even asymptomatic, those mild or moderate cases are still contagious and move toward severe/critical.3 Once the mild/moderate case becomes severe/critical, it is always accompanied by pneumonia and multiorgan injuries. As the virus is still spreading, finding out the initial hits of viral infection is important to minimize the mild/moderate population, prevent disease aggravation and organs dysfunction. As the virus is still spreading, finding out the initial hits of viral infection is important to minimize the mild/moderate population, prevent disease aggravation and organs dysfunction.

A report showed that 70% of acutely ill patients had decreased levels of serum calcium which is associated with a poor prognosis.4 Previous studies of COVID-19 patients showed that severe/critical cases with electrolyte disturbance including calcium unbalance,5 hypokalemia in COVID-19 patients had been associated with ECG changes including long QT.6 But the role of abnormal calcium level in COVID-19 is unknown.

Zhou et al7 investigated COVID-19 patients with different serum calcium levels. They found that both mild/moderate and severe critical cases observed showed low calcium level in the early stage of viral infection, while the severe/critical cases showed significant lower calcium level than mild/moderate cases in the early stage. They also found that low calcium level related to severe/critical multiorgan injuries especially in the mild/moderate population. Proinflammatory cytokine IL-6 also correlated to calcium change in both mild/moderate and severe/critical cases.

In conclusion, calcium balance is a primal hit of COVID-19 and a biomarker of clinical severity at the beginning of symptom onset. Calcium is closely associated with virus-associated multiple organ injuries and the increase in inflammatory cytokines. Results provide a new, important indicator of COVID-19 patients from mild/moderate to severe/critical: serum calcium.

 

Feel free to reach us for queries admin(at)youngatbones.com

 

Connect with us on:

facebook – twitter – LinkedIn – Instagram

 

References:

  1. Guan, W.J., Ni, Z.Y., Hu, Y. et al. (2020) Clinical characteristics of coronavirus disease 2019 in China. Engl. J. Med. 382, 1708–1720, https://doi.org/10.1056/NEJMoa2002032.
  2. World Health Organization Coronavirus disease 2019 (COVID-19) Situation Report 124. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200523-covid-19-sitrep-124.pdf?sfvrsn=9626d639
  3. Wu, Z. and McGoogan, J.M. (2020) Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA 323, 1239–1242, https://doi.org/10.1001/jama.2020.2648.
  4. Desai, T.K., Carlson, R.W. and Geheb, M.A. (1988) Prevalence and clinical implications of hypocalcemia in acutely ill patients in a medical intensive care setting. J. Med. 84, 209–214, https://doi.org/10.1016/0002-9343(88)90415-9
  5. Lippi, G., South, A.M. and Henry, B.M. (2020) Electrolyte imbalances in patients with severe coronavirus disease 2019 (COVID-19). Clin. Biochem. 57, 262–265, https://doi.org/10.1177/0004563220922255
  6. Chen, D., Li, X., Song, Q., Hu, C., Su, F., Dai, J. et al. (2020) Assessment of hypokalemia and clinical characteristics in patients with coronavirus disease 2019 in Wenzhou, China. JAMA Netw. Open 3, e2011122, https://doi.org/10.1001/jamanetworkopen.2020.11122.
  7. Zhou X., Chen D., Wang L., Zhao Y., Wei L., Chen Z. Yang B. (2020) Low serum calcium: a new, important indicator of COVID-19 patients from mild/moderate to severe/critical. Bioscience Reports (2020) 40 BSR20202690, https://doi.org/10.1042/BSR20202690

 

Disclaimer: This material is for informational purpose only. It does not replace the advice or counsel of a doctor or health care professional.  You should consult with, and rely only on the advice of, your physician or health care professional.
Contacts
  • Head Office: DEVASHISH BUILDING, ALKEM HOUSE, SENAPATI BAPAT ROAD, LOWER PAREL, MUMBAI - 400 013
  • Phone: +91 22 3982 99 99
  • Phone: 1800 212 0767
  • Email: contact@alkem.com